Analisis Molekuler Resistensi terhadap Pasien dengan Multidrug Resistance Tuberculosis (MDR TB)
DOI:
https://doi.org/10.55606/termometer.v2i3.3922Keywords:
Mycobacterium tuberculosis, Multidrug Resistance TB (MDR TB), Molecular Structure, Isoniazid, RifampicinAbstract
Mycobacterium tuberculosis is a bacterium that causes tuberculosis disease, which in the healing process requires a long time because this bacterium has a resting phase or what is called a dormant phase. This is one of the factors that cause patients who are undergoing tuberculosis treatment to experience saturation and stop treatment before the specified time. Resistance to antituberculosis drugs is a result of negligence in treatment so that bacteria become resistant to several types of antituberculosis drugs called multidrug resistance tuberculosis (MDR TB). This systematic review aims to examine the molecular structure of Mycobacterium tuberculosis bacteria and its correlation with the mechanism of resistance to antituberculosis drugs, especially Isoniazid and Rifampicin..
References
Adam, L. 2020. Pengetahuan Penderita Tuberkulosis Paru Terhadap Kepatuhan Minum Obat Anti Tuberkulosis. Jambura Health and Sport Journal. 2(1), pp. 12-18. ISSN: 2656-2863.
Agus, R., Purnamasari, W. O. S., Parura, R. D., Silang, F., dan Massi, M. N., 2022. Cloning, Production And Responses Of The sMTL-13 Protein (13 kDa Lectin Secretion) Mycobacterium Tuberculosis Against Interleukin 6. Biodiversitas Journal of Biological Diversity, 23(12), pp. 6208-6212.
Aristiana, C. D. & Wartono, M. 2018. Faktor-faktor yang Mempengaruhi Kejadian Multi Drug Resistant Tuberkulosis (MDR-TB). JbBiomedKes. 1(1), pp. 65- 75. DOI: 10.18051/JBiomedKes.2018.v1.65-74.
Arumingtyas, E. L. 2019. Mutasi: Prinsip Dasar dan Konsekuensi. Universitas Brawijaya Press. ISBN: 978-602-432-826-9
Budi I, Ardhila Y, Sari I, Septiawaty D, 2018. Analisis Faktor Resio Kejadian Penyakit Tuberkulosis bagi Masyarakat Daerah Kumuh Kota Palembang. Jurnal Kesehatan Lingkungan Indonesia:17(2):87-94
Chitale, P., Lemenze, A. D., Fogarty, E. C., Shah, A., Grady, C., Odom-Mabey, A. R., Johnson, W. E., Yang, J. H., Eren, A. M., Brosch, R., Kumar, P., dan Alland, D., 2022. A Comprehensive Update To The Mycobacterium tuberculosis H37Rv Reference Genome. Nature communications, 13(1), p. 7068
De Martino, M., Lodi, L., Galli, L., dan Chiappini, E., 2019. Immune response to Mycobacterium tuberculosis: a narrative review. Frontiers in pediatrics, 7, 350
Delannoy, C., Huang, C., Coddeville, B., Chen, J. Y., Mouajjah, D., Groux- Degroote, S., Harduin-Lepers, A., Khoo, K., Guerardel, Y., dan Elass- Rochard, E., 2020. Mycobacterium bovis BCG Infection Alters The Macrophage N-Glycome. Molecular omics, 16(4), pp. 345-354
Dookie et al., 2018. Evolution of Drug Resitance in Myobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care.Journal of Antimicrobial Chemotherapy: 73 (5): 1138-1151
Fitzgerald, D. M., dan Rosenberg, S. M., 2019. What Is Mutation? A Chapter In The Series: How Microbes "Jeopardize" The Modern Synthesis. PLoS genetics, 15(4), p. e1007995
Gavrilov, M., Yang, J.Y., Zou, R.S., Ma, W., Lee, C.Y., Mohapatra, S., Kang, J., Liao, T.W., Myong, S. and Ha, T., 2022. Engineered Helicase Replaces Thermocycler in DNA Amplification While Retaining Desired PCR Characteristics. Nature Communications, 13(1), p.6312
Global tuberculosis report 2022. Geneva: World Health Organization; 2022 (https://iris.who.int/handle/10665/363752).
Gordon, S. V., dan Parish, T., 2018. Microbe Profile: Mycobacterium tuberculosis: Humanity's Deadly Microbial Foe. Microbiology, 164(4), pp. 437-439
Gupta, M., Wu, H., Arora, S., Gupta, A., Chaudhary, G. and Hua, Q., 2021. Gene Mutation Classification Through Text Evidence Facilitating Cancer Tumour Detection. Journal of Healthcare Engineering, 2021, pp.1-16
Hu, T., Chitnis, N., Monos, D., dan Dinh, A., 2021. Next-Generation Sequencing Technologies: An Overview. Human Immunology, 82(11), pp. 801-811
HUTABARAT, HOTNIDA DINAULI. GAMBARAN HASIL PEMERIKSAAN Mycobacterium Tuberculosis MENGGUNAKAN GENEXPERT PADA SUSPECT TB DI RUMAH SAKIT UMUM PIRNGADI MEDAN. 2019.
Jang, J. G., dan Chung, J. H., 2020. Diagnosis and Treatment of Multidrug- Resistant Tuberculosis. Yeungnam University Journal of Medicine, 37(4), pp. 277-285
Kadri, K., 2019. Polymerase Chain Reaction (PCR): Principle and Applications. Synthetic Biology-New Interdisciplinary Science. IntechOpen
Kementerian Kesehatan Republik Indonesia, 2022. Profil Kesehatan Indonesia Tahun 2021. Jakarta.
Kementerian Kesehatan Republik Indonesia, Petunjuk Teknis Manajemen Terpadu Pengendalian Tuberkulosis Resistan Obat: Direktorat Jenderal Pengendalian Penyakit dan Penyehatan Lingkungan, 2018
Kolbe, K., Veleti, S. K., Reiling, N., dan Lindhorst, T. K., 2019. Lectins of Mycobacterium tuberculosis-Rarely Studied Proteins. Beilstein Journal of Organic Chemistry, 15(1), pp. 1-15
Lange, C., Aarnoutse, R. E., Alffenaar, JW. C., Bothamley, G., Brinkmann, F., CostaJ, Chesov, Det al., 2019 Management Of Patients With Multidrug- Resistant Tuberculosis The International Journal Of Tuberculosis and Lung Disease, 23(6), pp. 645-662.
Liu Q, Yang D, Qiu B, Martinez L, Ji Y, Song H, et al. (2021) Drug Resistance Gene mutations and Treatment Outcomes in MDR-TB: A Prospective Study in Eastern China. PLoS Negl Trop Dis 15(1): e0009068. https://doi.org/10.1371/ journal.pntd.0009068
Liu, Q., Yang, D.Qiu, B., Martinez, L., Ji, Y., Song, H, dan Wang, J, 2021. Drug Resistance Gene Mutations and Treatment Outcomes In MDR-TB: A Prospective Study In Eastern China. PLOS Neglected Tropical Diseases, 15(1), p. e0009068
Methods used by WHO to estimate the global burden of TB disease. Geneva: World Health Organization; 2021 (https://www.who.int/publications/m/item/methods-used-by-who-to-estimate-the-global-burden-of-tb-disease).
Novianti., Simarmata, O, S., Lolong, D,B., PEMANFAATAN TES CEPAT MOLEKULER (TCM) GENEXPERT SEBAGAI ALAT DIAGNOSTIK TB PARU DI RSUD WANGAYA KOTA DENPASAR, Jurnal Ekologi Kesehatan, 2020; (Desember 2019):Vol. 18 No. 3, 135-148.
Pusat Data dan Informasi Kementerian Kesehatan Republik Indonesia, Infodatin Tuberkulosis, 2018, didapat dari http://www.pusdatin.kemkes.go.id/pdf.php?id=18101500001
Umar, 2022, Mycobacterium tuberculosis: Kajian Mekanisme Resistensi Intrinsik dan Resistensi Genetik Terhadap Obat Anti Tuberkulosis, Jawa Barat, PT Pusat Literasi Dunia Kepuh, Lemahsugih, Majalengka, Jawa Barat, Indonesia.
World Health Organization, Global Tuberculosis Report 2023, 2023.
Zhai, W., Wu, F., Zhang, Y., Fu, Y., dan Liu, Z., 2019. The Immune Escape Mechanisms Of Mycobacterium tuberculosis. International Journal of Molecular Sciences, 20(2), p. 340
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Termometer: Jurnal Ilmiah Ilmu Kesehatan dan Kedokteran
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
